Related Experiment Video
Updated: May 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Serratia marcescens meningitis: epidemiology, prognostic factors and treatment outcomes
Yen-Mu Wu1, Po-Chang Hsu, Chien-Chang Yang
1Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Background/Purpose:
Serratia marcescens is a rare pathogen of central nervous system infections. This study was to investigate the epidemiology, prognostic factors, and treatment outcomes of S. marcescens meningitis.
Methods:
This retrospective analysis included 33 patients with culture-proven S. marcescens meningitis hospitalized between January 2000 and June 2011.
Results:
Of the 33 patients enrolled, only one did not receive neurosurgery before the onset of S. marcescens meningitis. Patients with S. marcescens meningitis had higher ratios of brain solid tumors (54.5%) and neurosurgery (97.0%) with a mortality rate of 15.2%. The mean interval between the first neurosurgical procedure and the diagnosis of meningitis was 17.1 days (range, 4-51 days). Only one third-generation cephalosporin-resistant S. marcescens isolate was recovered from the patients' cerebrospinal fluid (CSF) specimens. Compared with the favorable outcome group (n = 20), the unfavorable outcome group (n = 13) had a higher percentage of brain solid tumors, more intensive care unit stays, and higher Sequential Organ Failure Assessment score, CSF lactate and serum C-reactive protein concentrations at diagnosis of meningitis. Under the multiple regression analysis, CSF lactate concentration ≥2-fold the upper limit of normal (ULN) was independently associated with unfavorable outcomes (odds ratio, 7.20; 95% confidence interval, 1.08-47.96; p = 0.041).
Conclusion:
S. marcescens meningitis is highly associated with neurosurgical procedures for brain solid tumors. CSF lactate concentration ≥2x ULN may predict an unfavorable outcome. Its mortality is not high and empiric treatment with parenteral third-generation cephalosporins may have a satisfactory clinical response.
Insights
Serratia marcescens meningitis, often linked to neurosurgery for brain tumors, has a 15.2% mortality rate. Elevated cerebrospinal fluid lactate may predict poor outcomes.
Area of Science:
- Neuroscience
- Infectious Diseases
- Oncology
Background:
- Serratia marcescens is a rare cause of central nervous system infections.
- Meningitis due to S. marcescens is infrequently encountered but can be serious.
Purpose of the Study:
- To investigate the epidemiology of S. marcescens meningitis.
- To identify prognostic factors and treatment outcomes for S. marcescens meningitis.
Main Methods:
- Retrospective analysis of 33 patients with culture-proven S. marcescens meningitis.
- Data collected from January 2000 to June 2011.
Main Results:
- 97% of patients had undergone neurosurgery, often for brain solid tumors (54.5%).
- Mortality rate was 15.2%. Higher Sequential Organ Failure Assessment scores and elevated CSF lactate predicted unfavorable outcomes.
- CSF lactate concentration ≥2x upper limit of normal was an independent predictor of unfavorable outcomes (OR, 7.20; P=.041).
Conclusions:
- S. marcescens meningitis is strongly associated with neurosurgical procedures for brain tumors.
- Elevated CSF lactate may indicate a poor prognosis.
- Empirical treatment with third-generation cephalosporins appears effective with a low mortality rate.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Clinical Significance of Antibiotic Resistance
Brain Abscess l: Introduction
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
